The Stock Of AbCellera Biologics Inc (NASDAQ: ABCL) Was Forecast By Analysts To Close At 34 Per Share By 2025.
In the last trading session, 8.43 million AbCellera Biologics Inc (NASDAQ:ABCL) shares changed hands as the company’s beta touched 0.61. With the company’s per share